CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- 4 Open-market sale Chief Executive Officer sold 1,207 shares at $2.81 ($3,392)
- 4 Open-market sale Chief Executive Officer sold 1,220 shares at $3.11 ($3,794)
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 4 Open-market sale Chief Medical Officer sold 1,205 shares at an average $5.70 ($6,870)
- 4 Open-market sale Chief Executive Officer sold 1,264 shares at $5.51 ($6,965)
- 424B5 Offering Prospectus
- 4 Open-market sale Chief Executive Officer sold 1,350 shares at $7.26 ($9,801)
- 8-K Event Other events
- 4 Open-market sale Chief Medical Officer sold 1,204 shares at $11.67 ($14,051)
- 4 Open-market sale Chief Executive Officer sold 1,228 shares at $11.67 ($14,331)
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure
- 4 Open-market sale Chief Executive Officer sold 20,350 shares at $0.68 ($13,838)
- 4 Grant or award Director acquired 89,286 shares (grant or award)
- 4 Grant or award Director acquired 89,286 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
Page 19 of 26 · 506 filings